Daniel Mark James
SEC insider (Form 3/4/5 filer). CIK 0002092593. Chief Financial Officer at ATOSSA THERAPEUTICS, INC. (ATOS). 2 reported Form 4/5 transactions since Sep 2024; latest on Mar 26, 2026. Located in SEATTLE, WA.
Companies Daniel Mark James has filed insider reports for
- ATOSSA THERAPEUTICS, INC. (ATOS): Officer, Chief Financial Officer
Daniel Mark James
CIK: 0002092593
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ATOS
ATOSSA THERAPEUTICS, INC.
Officer